This finding was later combined with research by Joel Habener and jointly published in JCI.11 The team of Jens Juul Holst at the University of Copenhagen in Denmark published a report in FEBS Letters, reaching the same conclusion in January 1987.23 In December 1987, Stephen Blooms team confirmed in a Lancet paper that GLP-1(7-36) is a human intestinal hormone that stimulates insulin production in the pancreas and lowers blood sugar.24 GLP-1, used for treating diabetes, is quickly broken down in the body, requiring high doses that can cause side effects like nausea
The evidence reveals significant heterogeneity in the effects of GLP-1RAs across different cancer types
Bolger, A
Whenever significant weight loss occurs, some muscle loss can happen alongside fat loss
Its composition includes active fragments of nerve growth factor, BDNF, ciliary neurotrophic factor, and other neurotrophic molecules
More from this author: Idelalisib plus rituximab improves progression-free survival in relapsed CLL, SSRI use during pregnancy not linked to increased risk of autism,Combo antifungal therapy most effective treatment for cryptococcal meningitis Image: CC/Wiki 2012-2014 2minutemedicine.com
